Literature DB >> 33585699

miR-142-5p promotes cervical cancer progression by targeting LMX1A through Wnt/β-catenin pathway.

Lijuan Ke1, Yanping Chen1, Yiying Li2, Zheng Chen1, Yihui He3, Jiahua Liu1, Yingfeng Zhuang4.   

Abstract

BACKGROUND: Previous work has shown that miR-142-5p in cervical cancer tissues increased significantly compared with adjacent normal tissues. However, the function and the mechanism of miR-142-5p in cervical cancer have not been reported.
METHODS: Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was used to determine the gene expression levels. MTT, flow cytometry, and transwell assays were performed to explore the functions of miR-142-5p in HeLa cells. The potential target gene of miR-142-5p was investigated via luciferase reporter assays. The protein expression levels were analyzed by Western blotting.
RESULTS: We found that miR-142-5p expression was elevated but LIM homeobox transcription factor 1 alpha (LMX1A) was decreased in cervical cancer tissues and cells. Overexpression of miR-142-5p or knockdown of LMX1A inhibited cell apoptosis, promoted cell proliferation, migration, invasion abilities, and activated the Wnt/β-catenin pathway. However, knockdown of miR-142-5p or overexpression of LMX1A showed opposite results. LMX1A was identified as a direct target of miR-142-5p by luciferase reporter assays. Finally, rescue experiments demonstrated that LMX1A overexpression attenuated the carcinogenic effect of miR-142-5p mimic on HeLa cells.
CONCLUSIONS: These findings suggested that miR-142-5p might be a cervical cancer oncogene and could serve as a potential therapeutic target for the treatment of cervical cancer.
© 2021 Lijuan Ke et al., published by De Gruyter.

Entities:  

Keywords:  HeLa cells; LMX1A; Wnt/β-catenin pathway; cervical cancer; miR-142-5p

Year:  2021        PMID: 33585699      PMCID: PMC7862994          DOI: 10.1515/med-2021-0218

Source DB:  PubMed          Journal:  Open Med (Wars)


  18 in total

Review 1.  The evolution of gene regulation by transcription factors and microRNAs.

Authors:  Kevin Chen; Nikolaus Rajewsky
Journal:  Nat Rev Genet       Date:  2007-02       Impact factor: 53.242

2.  microRNA-9 selectively targets LMX1A to promote gastric cancer cell progression.

Authors:  Xiaohong Zhang; Yanqing Qian; Fan Li; Songhua Bei; Meiyi Li; Li Feng
Journal:  Biochem Biophys Res Commun       Date:  2018-09-24       Impact factor: 3.575

3.  miR-142-5p regulates pancreatic cancer cell proliferation and apoptosis by regulation of RAP1A.

Authors:  Rong Yao; Lijuan Xu; Bin Wei; Zhaoye Qian; Jiru Wang; Hongxia Hui; Yuan Sun
Journal:  Pathol Res Pract       Date:  2019-04-18       Impact factor: 3.250

Review 4.  Cervical cancer.

Authors:  Paul A Cohen; Anjua Jhingran; Ana Oaknin; Lynette Denny
Journal:  Lancet       Date:  2019-01-12       Impact factor: 79.321

5.  Aberrant microRNA expression in human cervical carcinomas.

Authors:  Qunxian Rao; Qingli Shen; Hui Zhou; Yongpai Peng; Jing Li; Zhongqiu Lin
Journal:  Med Oncol       Date:  2011-01-25       Impact factor: 3.064

6.  MicroRNA-494 promotes cervical cancer proliferation through the regulation of PTEN.

Authors:  Yong-Kang Yang; Wen-Yan Xi; Ru-Xing Xi; Jing-Yuan Li; Qin Li; Yan-E Gao
Journal:  Oncol Rep       Date:  2015-02-26       Impact factor: 3.906

7.  MicroRNA-142-5p promotes cell growth and migration in renal cell carcinoma by targeting BTG3.

Authors:  Lingqi Liu; Shuchao Liu; Qixin Duan; Liang Chen; Tianpeng Wu; Huijun Qian; Sixing Yang; Dianqi Xin; Zhisong He; Yinglu Guo
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

8.  Lmx1a regulates fates and location of cells originating from the cerebellar rhombic lip and telencephalic cortical hem.

Authors:  Victor V Chizhikov; Anne G Lindgren; Yuriko Mishima; Richard W Roberts; Kimberly A Aldinger; George R Miesegaes; D Spencer Currle; Edwin S Monuki; Kathleen J Millen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-24       Impact factor: 11.205

9.  An epigenetic marker panel for screening and prognostic prediction of ovarian cancer.

Authors:  Her-Young Su; Hung-Cheng Lai; Ya-Wen Lin; Yu-Ching Chou; Chin-Yu Liu; Mu-Hsien Yu
Journal:  Int J Cancer       Date:  2009-01-15       Impact factor: 7.396

10.  MicroRNA-204 inhibits cell migration and invasion in human cervical cancer by regulating transcription factor 12.

Authors:  Longwen Shu; Zongxin Zhang; Yunxiang Cai
Journal:  Oncol Lett       Date:  2017-11-03       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.